U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Zenocutuzumab
AE72RB1W1X
US Approved Rx (2024)
First approved in 2024
General
Names
9
Classification
2
Identifiers
7
Subunits
4
Related Substances
1
Zenocutuzumab
AE72RB1W1X
US Approved Rx (2024)
First approved in 2024
General
Approval Year
2024
711
Names
9
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
Zenocutuzumab
Official Name
English
MCLA-128
Preferred Name
English
ZENOCUTUZUMAB [USAN]
Common Name
English
MCLA128
Code
English
Immunoglobulin G1, bispecific, anti-(human epidermal growth factor receptors, HER2 and HER3) (humanized clone MCLA-128 ?1-chain), disulfide with humanized clone MCLA-128 light chain, dimer
Common Name
English
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of pancreatic cancer
FDA ORPHAN DRUG
750020
Antineoplastic Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antineoplastic Biological Agent
[C129821]
Antineoplastic Antibody
NCI_THESAURUS
C129822
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
7
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
CAS
1969309-56-5
PRIMARY
NCI_THESAURUS
C152948
PRIMARY
DRUG BANK
DB15559
PRIMARY
USAN
HI-231
PRIMARY
SMS_ID
300000025314
PRIMARY
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
AE72RB1W1X
Zenocutuzumab